bih.button.backtotop.text
BROWSE BY TEST NAME
#
%
1
2
3
5
8
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Clear
 
Test Code (รหัสการทดสอบ):
090-10-1046-01

Order Name (ชื่อการทดสอบ):
%CD19

 
Specimen / Container (สิ่งส่งตรวจ/ภาชนะ):
Blood/ K3 EDTA (K3E) (Lavender Top) 3 mL, 1 tube
 
Turnaround Time (ระยะเวลารอผล):
Collected specimen to report within 1 day
 
Useful For (ประโยชน์การทดสอบ):
Useful for follow-up and diagnostic evaluation of primary cellular immunodeficiencies, including severe combined immunodeficiency.

T-cell immune monitoring following immunosuppressive therapy for transplantation, autoimmunity, and other immunological conditions where such treatment is utilized.

Assessment of T-cell immune reconstitution post hematopoietic cell transplantation.

Early screening of gross quantitative anomalies in T cells in infection or malignancies
 
Methodology (วิธีการทดสอบ):
Flow cytometry
 
Test List In Profile (การทดสอบใน Profile):
WBC count
% Lymphocyte
CD3 Cell Count
% CD3
% CD19
 
AliasesName (ชื่อเรียกอื่นๆ) :
CD19 count
 
 
 
Test Code (รหัสการทดสอบ):
090-10-1046-01

Order Name (ชื่อการทดสอบ):
%CD19

 
Collection Specimen Or Container (สิ่งส่งตรวจ/ภาชนะ):
Blood/ K3 EDTA (K3E) (Lavender Top) 3 mL, 1 tube
 
Specimen Testing Type (สิ่งส่งตรวจที่ใช้ในการทดสอบ):
Blood, minimum volume 2 mL
 
Sub Mission Container (ภาชนะส่งตรวจ):
Original tube
 
Rejection Criteria (เกณฑ์ปฏิเสธสิ่งส่งตรวจ):
Clotted specimen will be rejected.
 
Specimen Stabillity (ความคงตัวของสิ่งส่งตรวจ):
Specimen Type Temperature Time
Blood Refrigerated, 18oC to 24oC 24 hours
 
 
 
Test Code (รหัสการทดสอบ):
090-10-1046-01

Order Name (ชื่อการทดสอบ):
%CD19

 
Method detail (วิธีการทดสอบ):
Flow cytometry
 
Schedule (ตารางการทดสอบ):
Tested Daily (24 hours)
 
Turnaround Time (ระยะเวลารอผล):
Collected specimen to report within 1 day
 
Performing Location (หน่วยงานที่ทำการทดสอบ):
Hematology, Laboratory Department Tel. 17254
 
 
 
Test Code (รหัสการทดสอบ):
090-10-1046-01

Order Name (ชื่อการทดสอบ):
%CD19

 
 
Clinical Information (ข้อมูลทางคลินิก):
Abnormalities in the number and percent of T (CD3, CD4, CD8), B (CD19), and NK (CD16+CD56) lymphocytes have been described in a number of different disease conditions. In patients who are infected with HIV, the CD4 count is measured for AIDS diagnosis and for initiation of antiviral therapy. The progressive loss of CD4 T-lymphocytes inpatients infected with HIV is associated with increased infections and complications. The Public Health Service has recommended that all HIV-positive patients be tested every 3 to 6 months for the level of CD4 T lymphocytes.

Lymphocyte subset quantitation is also very useful in the evaluation of patients with primary immunodeficiencies of all ages, including follow-up for newborn screening for severe combined immunodeficiency (SCID) and immune monitoring following immunosuppressive therapy for transplantation, autoimmunity, or any other relevant clinical condition where immunomodulatory treatment is used.

It is also helpful as a preliminary screening assay for gross quantitative anomalies in any lymphocyte subset, whether related to malignancies or infection.
 
Reference Value (ค่าอ้างอิง):
4.4 - 21.2
 
Clinical Reference (เอกสารอ้างอิง):
  1. Manufacturer’s reagent package insert, Cyto-Stat® TrichromeTM CD 45-FITC/ CD19-RD1/CD3-PC5 REF 6607072. Beckman Coulter, Inc. U.S.A. 2014
  2. http://www.mayomedicallaboratories.com (Retrieved: 22 Jan 2019)